Advertisement

Advertisement

ERNA Stock Latest News

Eterna Therapeutics Faces Nasdaq Delisting Risk After Notice

Company AnnouncementsEterna Therapeutics Faces Nasdaq Delisting Risk After Notice

Ernexa Therapeutics files $50M mixed securities shelf

PremiumThe Fly

Ernexa Therapeutics files $50M mixed securities shelf

27d ago

Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure

PremiumCompany Announcements

Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure

1M ago

Eterna Therapeutics Completes Public Offering to Bolster Capital

PremiumCompany Announcements

Eterna Therapeutics Completes Public Offering to Bolster Capital

2M ago

Ernexa Therapeutics prices 21M shares at 50c in public offering

PremiumThe Fly

Ernexa Therapeutics prices 21M shares at 50c in public offering

2M ago

Ernexa Therapeutics files to sell common stock, warrants, no amount given

PremiumThe FlyErnexa Therapeutics files to sell common stock, warrants, no amount given

2M ago

Ernexa selected as company for JETRO Japan entry acceleration program

The Fly

Ernexa selected as company for JETRO Japan entry acceleration program

2M ago

Ernexa Therapeutics completes Pre-IND meeting with FDA

The Fly

Ernexa Therapeutics completes Pre-IND meeting with FDA

3M ago

Ernexa Therapeutics presents preclinical data at ASH meeting on ERNA-101

PremiumThe Fly

Ernexa Therapeutics presents preclinical data at ASH meeting on ERNA-101

4M ago

Ernexa Therapeutics appoints Ira Winer to Scientific, Medical Advisory Board

PremiumThe Fly

Ernexa Therapeutics appoints Ira Winer to Scientific, Medical Advisory Board

4M ago

Ernexa Therapeutics reports Q3 operating loss $2M vs $2.3M last year

PremiumThe Fly

Ernexa Therapeutics reports Q3 operating loss $2M vs $2.3M last year

5M ago

3 Penny Stocks to Watch Now, 10/30/25

PremiumMarket News

3 Penny Stocks to Watch Now, 10/30/25

5M ago

Ernexa Therapeutics, Cellipont Bioservices enter collaboration

PremiumThe FlyErnexa Therapeutics, Cellipont Bioservices enter collaboration

5M ago

Ernexa Therapeutics reports 1H operational loss $5.4M vs $10.7M last year

The Fly

Ernexa Therapeutics reports 1H operational loss $5.4M vs $10.7M last year

7M ago

Ernexa Therapeutics regains compliance with Nasdaq listing rules

The Fly

Ernexa Therapeutics regains compliance with Nasdaq listing rules

9M ago

Ernexa Therapeutics expands Scientific Advisory Board

PremiumThe Fly

Ernexa Therapeutics expands Scientific Advisory Board

10M ago

Ernexa secures $6M in second closing under securities purchase agreement

PremiumThe Fly

Ernexa secures $6M in second closing under securities purchase agreement

10M ago

Eterna Therapeutics Implements 1-for-15 Reverse Stock Split

PremiumCompany Announcements

Eterna Therapeutics Implements 1-for-15 Reverse Stock Split

10M ago

Eterna Therapeutics trading halted, news pending

PremiumThe Fly

Eterna Therapeutics trading halted, news pending

10M ago

Ernexa Therapeutics files to sell 57.05M shares of common stock for holders

PremiumThe FlyErnexa Therapeutics files to sell 57.05M shares of common stock for holders

10M ago

Ernexa Therapeutics announces 1-for-15 reverse stock split

The Fly

Ernexa Therapeutics announces 1-for-15 reverse stock split

10M ago

Eterna Therapeutics Completes $6M Private Placement

Company Announcements

Eterna Therapeutics Completes $6M Private Placement

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >